Cheekbone Fat Injections: Fat or Bone?
Fat-dissolving shots help a cheekbone only when the fullness is soft fat, not bone or hollowing. How to tell, the risks, and fitting it into a Seoul trip.
Published
Updated

Author
Wi Young-jinChief Director, Myeongdong
Seoul National University College of Medicine · Seoul National University Hospital Specialist
→
Fat-dissolving injections can slim the cheekbone area only when the fullness you see is a soft layer of fat under the skin. They can't change bone, and if your cheekbones stand out because the cheek below has flattened, dissolving fat over them can leave your face looking more sunken rather than slimmer.
That's the short reason cheekbone fat-dissolving reviews read like two different treatments. Some people describe a softer upper cheek; others say their face looked thinner and older. Both can be true, because the same injection was used on different causes.
If you're planning a trip to Seoul and wondering whether to fit cheek fat injections in, the first question isn't how many sessions you'll need. It's what is actually making your cheekbones look prominent. In this article, we'll cover how to tell bone from fat from hollowing, where these injections stand for the face, which risks matter near the cheekbone, and how to plan around a short trip.
Bone, fat, or hollowing: which type of cheekbones do you have?
Prominent cheekbones usually come from one of three things, or a mix of them: the bone itself is wide or projects forward, a soft layer of fat sits over it, or the cheek below has lost volume so the bone looks sharper by contrast.
When you search "types of cheekbones," you mostly find high versus low, or wide versus narrow. Those describe the bone's shape and position, and a fat-dissolving injection doesn't touch any of it. It acts on fat under the skin (subcutaneous fat), so the useful question for treatment is different: how much of what you see is soft tissue, and which soft tissue.
That second part matters more than most people expect. An anatomy study of the cheek concludes that the term "malar fat" is probably a misnomer, because this region is composed of both distinct superficial and deep fat compartments.
The same study describes how diminished volume of the deep medial cheek fat (a deeper pad on the inner cheek) leads to an excess skin envelope and the illusion of a more prominent fold beside the nose.
Aging shifts things too. A review of midface aging reports that the fat compartments of the midface appear to migrate downward with age, deepening the groove between the lower eyelid and the cheek (palpebromalar groove).
So the fullness "above the cheekbone" in a selfie can sit right next to an area that's losing volume. Take fat out of that picture and you may sharpen the very contrast you were trying to soften.
Here's a rough way to sort your own face before a consultation. It isn't a diagnosis, but it tells you which question to bring:
Bone-led: the cheekbone stands out even at your leanest, and what you feel under your fingertips is a firm edge with little soft tissue sliding over it.
Fat-led: there's a soft layer you can gently pinch that moves over the bone, and it has stayed through weight changes.
Hollowing-led: your cheekbones look more prominent than they used to, mainly because the cheek below or the area under the eye has flattened.
Mixed: a wide bone with some soft fullness on top.

Can fat-dissolving injections treat cheek fat at all?
They can be used there, but the cheek isn't an approved area for them, and the evidence for it is much thinner than for the chin.
Most of the research on fat-dissolving shots is about DCA (deoxycholic acid), the ingredient in Kybella. A 2026 review of injection lipolysis states that submental fat (double chin) is the only indication approved by major regulatory bodies such as the FDA and China's NMPA.
The same review notes that the FDA label for Kybella states that safe and effective use outside the submental region has not been established.
Off-label facial use does happen. A systematic review of non-submental uses found that many cosmetic surgeons use DCA off-label in other areas, including the face, and reported a safety profile similar to approved use, while concluding that larger-scale studies are warranted.
The 2026 review is more guarded. It advises that clinicians considering off-label applications should exercise particular caution, obtain thorough informed consent, and strictly adhere to safety protocols.
The facial research is also small. That systematic review identified ten pertinent articles in total, covering the face, the bra line, the foot, and the outer hip (gluteotrochanteric region).
What that means for you: a fixed number of cheek sessions isn't something the research can hand you up front. The plan should come from an exam of your face, and it's fair to ask for the product's name, its active ingredient, and what it's approved for.

Why do cheekbone fat-dissolving reviews split so sharply?
Mostly because the injection that helps a fat-led cheek is the same one that can hollow a bone-led or aging one.
DCA doesn't just shrink fat cells for a while. The review describes the released fat being cleared by immune cells, resulting in an irreversible reduction in fat cell number.
That's the point when fat really was the problem. It's also why the target has to be right: fat cells that are gone aren't expected to return the way swelling settles, and a cheek that was never fat-led has little layer to spare.
The review raises the same concern for another part of the face. For the small pouches beside the mouth, it says dose control is critical to prevent overcorrection leading to depressions or skin laxity.
Here's the order I'd check a prominent cheekbone in, one layer at a time:
Bone first. If the prominence is mainly bone, a fat-dissolving injection is the wrong tool. An injection doesn't change bone shape.
Then the cheek below. If a hollow under the cheekbone or under the eye is what makes the bone stand out, removing fat above it works against you. The conversation then turns to volume or lifting, not reduction.
Then the soft layer itself. If there's a distinct, soft layer over the bone that has stayed through weight changes, and the cheek below still has good support, a cautious, limited fat-dissolving plan is a reasonable option to discuss.
So if you have wide cheekbones and you've read both kinds of reviews, here's my read. If what bothers you feels firm and bony, skip fat-dissolving shots for the cheek. If it's soft, pinchable, and the cheek below is still full, it's worth an exam to see how much of it these injections can reach. With a mixed face, the goal is a modest change to the soft part only, not a smaller-looking bone.

Side effects and risks near the cheekbone
Swelling and firmness after injection are expected. What makes the cheek trickier than the chin is what runs underneath it.
DCA works by rupturing fat cells, and the review explains that this form of cell death triggers a strong inflammatory response. That's why some swelling afterward is part of the process rather than a surprise.
The detail I'd point to in any cheek plan is a line, not a dose. The cheekbone continues back toward your ear as a bony bar (the zygomatic arch), and the tube that carries saliva from the gland in front of your ear to your mouth (the parotid duct) crosses the cheek below it.
A 2026 cadaver study notes that the parotid duct runs superficially across the midface and is often encountered during aesthetic or surgical procedures.
In that study, at the front edge of the chewing muscle (masseter), the duct was located slightly above an imaginary line from the small flap in front of the ear (tragus) to the corner of the mouth in 84.4% of specimens.
The review also says injection around the buccal fat pad should avoid the parotid duct and buccal branches of the facial nerve.
Gland irritation has been reported in a nearby area: a case report describes parotitis (inflammation of that salivary gland) following routine use of sodium deoxycholate for jowl contouring.
Put together, the soft spot just under the cheekbone that many people want gone is the zone that calls for the most restraint. That's the question worth asking at any consultation: where does the treatment zone stop below the cheekbone, and how deep does it go?
Your history matters too. A review of serious side effects after DCA for under-chin and jowl fat advises excluding patients with prior use of injectable fat-dissolving agents, those using blood thinners, and pregnant patients. Mention any of these, plus fillers or threads in the cheek, before anything is booked.
Swelling that slowly settles is expected. Some signs are different: pain that's unusual or getting worse, skin that changes color, fever, or a face that starts to move unevenly. If any of these show up, seek medical care right away rather than waiting it out.

Fitting cheek fat injections into your Seoul trip
You don't need to postpone your flight home because of a fat-dissolving injection, as long as you didn't have sedation that day.
Photos and sightseeing are a separate question. Swelling is expected, as above, and how visible it is on a given day varies from person to person. If a particular photo day matters to you, say so at the consultation so the treatment date can be weighed against it.
One visit still means something. Most treatments like this change your face gradually rather than all at once, and that suits the cheek, where the cautious approach is to take a little and look again. On a short trip, one visit can settle the bone-or-fat question and, if it fits, a first limited session. Whether more is worth doing is decided on a later trip, after the swelling has gone and you can compare your own photos.
For those photos, take your own before you start: same light, same angle, head level, no smile. Then retake them the same way later. That comparison tells you more than any review.
Once you're home, if something about the area looks off, you can send photos to the clinic on WhatsApp. If it's something bigger, like fever, spreading redness, skin turning dark, or your face moving unevenly, see a local doctor first.

The bottom line: name the cause before you dissolve anything
Cause first: sort bone, fat, and hollowing before thinking about sessions.
Evidence: the cheek is an off-label area with much thinner evidence than the chin.
One-way change: the fat-cell reduction is irreversible, so take a little and reassess.
The line below the cheekbone: the saliva duct and nerve branches set where and how deep injections should stop.
Like any procedure, it comes with trade-offs, and individual results vary. Ultimately, the choice depends on your face, your goals, and your travel plans.
Before you book anywhere, ask one thing about the plan: where does the treatment zone stop below your cheekbone, and at what depth? A clear answer to that tells you the bone, the fat, and the duct have all been considered.
We're a dermatology clinic in Hapjeong, Seoul, one subway stop from Hongik University Station on Line 2. If you'd like a read on your cheekbones before you plan your trip, send Beautystone your travel dates with a front and a side photo on WhatsApp. Something like: "I'm in Seoul from [dates] and want to know if the fullness on my cheekbones is fat or bone. Front and side photos attached."

Lifting
Shurink Universe Results: 1st vs. 2nd Session

Contouring & Volume
How Long Does Juvelook Take? Skin vs. Volume

Contouring & Volume
Sculptra for Smile Lines: Hollow or Sagging?

skin
Rejuran Bumps on Day 2: What's Normal?

skin
Acne Cortisone Shot: 3 Signs It's Working

skin
리투오 주의사항, 시술 뒤 세안·화장·음주는 어떻게 하나요?



